Choroideremia

This is a rare eye condition that affects the back part of the eye, called the choroid. It causes a slow loss of vision, starting with trouble seeing at night. Over time, it can lead to complete blindness.

Condition

What people with Choroideremia report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Choroideremia

What It Is

Choroideremia is a rare inherited eye disease that slowly destroys the light-sensing tissue at the back of the eye. It affects the retina, the layer that turns light into signals for the brain, along with the cells that support it and the choroid, a network of blood vessels beneath it. As these layers waste away, vision is lost from the outside in. It mainly affects males. The first sign is usually trouble seeing in dim light or at night, often noticed in childhood. Over the following years, side (peripheral) vision gradually narrows, creating tunnel vision, while sharp central vision is usually kept well into adulthood. Central vision and color vision tend to decline later, often from middle age onward, and the condition eventually leads to blindness, most commonly in late adulthood. The pace differs a great deal from person to person, even within the same family.

Causes & Risk Factors

Choroideremia is caused by changes (variants) in a single gene, called CHM, which carries the instructions for a protein that cells need to move materials around inside themselves. Most of the body has a backup protein that can fill in, but the retina has very little of it, so the eye is the part that suffers. The CHM gene sits on the X chromosome, which shapes who is affected. Males have one X chromosome, so one altered copy is enough to cause the disease. Females have two, so a woman with one altered copy is usually a carrier: she typically has no symptoms, though an eye exam may show patchy changes in the retina and some carriers develop mild vision problems later in life. A carrier has a 50 percent chance of passing the variant to each child. Fathers with choroideremia cannot pass it to their sons, but all of their daughters will be carriers. Nothing a person does causes the condition or speeds it up in a known way.

How It's Diagnosed

An eye specialist usually suspects choroideremia from night blindness, a shrinking field of vision, a family history that fits the X-linked pattern and a distinctive appearance at the back of the eye during a dilated exam, where patches of missing tissue can expose the white wall of the eye underneath. Imaging and function tests show how far the disease has spread. Retinal photographs and autofluorescence imaging map the areas of healthy and lost tissue, optical coherence tomography (OCT) gives cross-section pictures of the retina, visual field testing measures side vision, and electroretinography (ERG) records how the retina responds to light. Because several other inherited retinal diseases, such as retinitis pigmentosa and gyrate atrophy, can look similar, the diagnosis is confirmed with genetic testing for a CHM variant. Genetic counseling can help family members understand whether they may be carriers and what testing involves.

Treatment Options

There is no approved treatment that stops or reverses choroideremia. Care focuses on protecting the vision that remains, treating complications and making daily life easier as sight changes. Gene therapy is the main focus of research. It uses a harmless virus to deliver a working copy of the CHM gene beneath the retina during eye surgery. In early trials some people's vision held steady or improved, but a large phase 3 trial did not reach its main goal, and the treatment is not approved. Results so far suggest gene therapy is more likely to slow damage than to restore lost sight, and the surgery itself commonly causes eye side effects. People interested in research can ask about current clinical trials. Some complications can be treated. Cataracts (clouding of the lens) are fairly common and can be removed surgically, though surgery in a fragile retina needs careful discussion. Swelling in the center of the retina (macular edema) may respond to eye drops such as dorzolamide, a carbonic anhydrase inhibitor. Low-vision services, including magnifiers, screen readers, good lighting, mobility training and work or school support, help people keep doing what matters to them. Lutein supplements have been studied, but a short trial showed no change in retinal function.

What to Expect

Choroideremia changes slowly over decades. Many people go through childhood and early adulthood with good central vision while gradually adapting to poor night vision and narrowing side vision. That combination can make dim rooms, nighttime travel, stairs, crowds and sports harder well before reading or recognizing faces becomes difficult. Decisions about driving, especially at night, often come up as the field of vision shrinks. Regular visits with an eye specialist track the disease with imaging and field tests and catch treatable problems like cataracts. Over time, many people use more low-vision tools and mobility support, and planning ahead for education, work and independent living helps. Because the condition runs in families, diagnosis often raises questions for parents, siblings and children, and genetic counseling can be useful at several points in life.

When to Seek Help

See an eye doctor if a child or adult has trouble seeing at night or in dim light, keeps bumping into things to the side, or has a family history of choroideremia. Women in affected families may want carrier testing and an eye exam, particularly before planning a pregnancy. Contact an eye care team promptly if vision changes suddenly, such as a quick drop or distortion in central vision, new flashes of light or a sudden shower of floaters. These can signal swelling or other problems in the retina that may be treatable, and they differ from the slow pace of choroideremia itself.

Questions to Ask Your Doctor

  1. 1.Has genetic testing confirmed a CHM variant, and should other family members be tested?
  2. 2.How much of my retina is still healthy, and how quickly is it changing?
  3. 3.Am I eligible for any gene therapy or other clinical trials, and what would taking part involve?
  4. 4.Which low-vision services or devices could help with my work, school or getting around?
  5. 5.Is it still safe for me to drive, and how will we decide when that changes?

Last reviewed • Oct 2026

Educational content, not medical advice.